Skip to main content
OpenTrials

Clinical trial condition

Genital Neoplasms, Male

Explore clinical trials studying Genital Neoplasms, Male. Study availability and eligibility vary by location and protocol.

5,014 public trials 1,020 recruiting studies
Refine in advanced search Browse all conditions

Genital Neoplasms, Male trial results

Recruiting

Study of GVV858 as a Single Agent or in Combination With Endocrine Therapy in Patients With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors

NCT07288359

Conditions
Advanced CCNE1-amplified Solid Tumors, Advanced HR+/HER2- Breast Cancer, Breast Diseases, +14 more
Locations
  • Tennessee Oncology PLLC Nashville, Tennessee, United States
  • START San Antonio, Texas, United States
  • Novartis Investigative Site Olomouc, Czechia
  • Novartis Investigative Site Odense C, Denmark
View all 15 locations
View Trial Details
Recruiting

A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer

NCT07225946

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations
  • Arizona Clinical Trials Chandler, Arizona, United States
  • Arkansas Urology Little Rock, Arkansas, United States
  • MemorialCare Orange Coast Medical Center Fountain Valley, California, United States
  • University Of California San Diego La Jolla, California, United States
View all 150 locations
View Trial Details
Recruiting

A Study on the Effects of Exercise Therapy on Signs of Prostate Cancer

NCT05751434

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +10 more
Locations
  • University of California, Los Angeles (Data and Specimen Analysis Only) Los Angeles, California, United States
  • Hartford Healthcare Alliance (Data collection only) Hartford, Connecticut, United States
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited protocol activities) Middletown, New Jersey, United States
View Trial Details
Recruiting

This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.

NCT07028853

Conditions
Cancer of the Prostate, Genital Diseases, Genital Diseases, Male, +11 more
Locations
  • Clearview Cancer Institute (Crestwood) Huntsville, Alabama, United States
  • Clearview Cancer Institute Huntsville, Alabama, United States
  • Ironwood Physicians P.C. dba Ironwood Cancer and Research Centers Chandler, Arizona, United States
  • Ironwood Physicians P.C. dba Ironwood Cancer and Research Centers Gilbert, Arizona, United States
View all 341 locations
View Trial Details
Recruiting

RecoverPC: Relugolix vs GnRH Agonist in Quality of Life

NCT05765500

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations
  • Brigham and Women's Hospital Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute at Foxborough Foxborough, Massachusetts, United States
View Trial Details
Recruiting

Adaptive Radiation Therapy (ART) Stereotactic Ablative Body Radiotherapy (SABR) for Primary Localized Prostate Cancer

NCT06325046

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +11 more
Locations
  • Mayo Clinic Health System in Albert Lea Albert Lea, Minnesota, United States
  • Mayo Clinic Health System-Mankato Mankato, Minnesota, United States
  • Mayo Clinic in Rochester Rochester, Minnesota, United States
  • Mayo Clinic Health System-Eau Claire Eau Claire, Wisconsin, United States
View Trial Details

Related conditions